about
Robotic surgery of the liver: Italian experience and review of the literature.Portal vein arterialization for hepatic artery thrombosis in liver transplantation: a case report, Doppler-ultrasound aspects, and review of the literature.Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication?A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.A risk score and a flowchart for liver retransplantation.Combined liver and kidney transplantation: a single-center experience.Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection.Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantation.More on Scylla and CharybdisTransient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsyHypoperfusion of Segment 4 in Right In Situ Split-Liver TransplantationFeasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experienceBack-Table Arterial Reconstructions in Liver Transplantation: Single-Center ExperienceLong-Term Outcome of Right Split In Situ Grafts in AdultsSplit-Liver Transplantation With Pediatric Donors: A Multicenter ExperienceLiver retransplantations with split in situ grafts in pediatric recipientsSingle centre experience with in situ right split liver transplantation in cirrhotic adultsCelsior solution and clinical liver transplantationEnteric nervous system in preservation, reperfusion, and rejection of the pig small bowelHigh-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantationLiver transplantation for viral hepatitis-associated cirrhosisMild course of c hepatitis after long-term follow-up in hepatitis b and c coinfected liver transplant recipientsNeoral increases bioavailability versus oral sandimmune after porcine small bowel transplantationReduced acute rejection after liver transplantation with neoral-based double immunosuppressionIntestinal damage evaluation in swine allograft small bowel through hyaluronic acid quantificationPharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantationSerotonin (5-HT): An enteroendocrine marker of rejection after small bowel allotransplantation in the pigSerotonin (5-HT): An enteroendocrine marker of reperfusion injury after liver-small bowel allotransplantation in the pigSmall bowel transplantation under oral immunosuppression: Experimental study in the pigTransplantation of small bowel alone or with the liver in pigs: Use of peripheral blood lymphocytes in monitoring rejectionA new ligament: the ≪ gastro-pancreatic ≫
P50
Q37265406-2B238BC8-2ABB-493B-81C6-A3F5CF50DBA4Q37763758-0E799C67-A705-4F15-BEDE-AD2345F3C4DBQ42203060-ED6B499A-CF96-4F6F-A0CB-A8F4F9C73B9EQ42657773-A23779E4-4A45-4BB4-883A-BF9889CB6E7BQ43533946-35829C33-A876-4B30-B381-5E94A6DD027BQ44101702-367A852D-4DCB-401B-AF0E-8CB8F4019963Q44256986-AD18F29B-6112-49FB-88A1-B94DB32469F0Q45403711-23FFBCE1-C7A9-4EC7-9123-9037AC06A3EBQ45752173-D24DF585-2EB2-4F76-B1A2-1E7E0B94013CQ47939869-5BC3B80C-E7FF-47E6-B378-53A654A5A2D1Q50503613-8B60F799-D83F-4033-88AC-073D2F1A68FFQ57597706-747C94C6-5050-4A7B-BFB5-1B24E0455683Q57597714-661187F0-D684-49A7-845C-FE3DDFC3D35EQ57597718-54F03217-B1F5-4357-A92F-41C86B7C1549Q57597724-B1488BD0-6556-405B-9F32-3CA612E9B7DBQ57597726-193D0A45-2167-4508-A141-2EA44C1C8F44Q57597728-067E74FB-BC68-4C30-8F23-5F2D8927739DQ57597729-4910446A-64F5-49A7-B0CE-B1299632DE26Q57597733-FB17E6ED-FB6D-470D-BB6A-603512CF2E87Q57597735-6DA964A7-C8FB-4B33-B83E-87D1D5BEB6A8Q57597737-288AFDFC-F8DE-47E2-9F4A-1C7FFC5AE64BQ57597739-58E3D5B5-FC00-40BB-B4BF-AF31A0E38DACQ57597741-DE943B92-7C50-4578-8E05-57FC55345C42Q57597742-01161FB7-F2CE-4175-8E90-73A60CEB048EQ57597744-08EEE4A6-E45B-44D2-BC49-0B3B956A8C69Q57597747-7929D980-1114-4DA9-B9F4-50135124A89BQ57597750-12736AE3-BE8D-414E-901A-EC8F6B27F2E6Q57597756-38A5786B-12A9-4C49-94F2-BBD1A30B4415Q57597758-806A3746-BE9A-4EB8-BBE4-8A24BC2ADB88Q57597761-6857062E-CA7E-4935-B024-C0F097BB8409Q57597763-CF84B166-3FEA-45F3-B4BD-10CC9D534F86Q57597767-30531B36-5F85-4DAC-866A-8B41B203AE59Q57597770-696DC0B6-9201-4718-8E92-539A08BA090EQ57597801-6B236D05-5D19-4575-9232-973E2AC3FC65
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Reggiani
@ast
Paolo Reggiani
@en
Paolo Reggiani
@es
Paolo Reggiani
@nl
type
label
Paolo Reggiani
@ast
Paolo Reggiani
@en
Paolo Reggiani
@es
Paolo Reggiani
@nl
prefLabel
Paolo Reggiani
@ast
Paolo Reggiani
@en
Paolo Reggiani
@es
Paolo Reggiani
@nl
P106
P1153
7005242451
P31
P496
0000-0001-6971-5547